ArticleJournal of personalized medicine2024

Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study.

Ji-Eun Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.